Vanguard Capital Management’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$68.6M Buy
948,762
+69,759
+8% +$5.41M ﹤0.01% 1735
2026
Q2
$60.3M Buy
879,003
+20,420
+2% +$1.16M ﹤0.01% 1830
2026
Q1
$55.1M Buy
+858,583
New +$78.3M ﹤0.01% 1809

Other funds holding WGS

Vanguard Capital Management's WGS Position: Q3 2026 in Review

Vanguard Capital Management increased its GeneDx Holdings (WGS) stake by 7.9% in Q3 2026, buying an estimated $5.41M and bringing the position to 948,762 shares worth $68.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1735.

Vanguard Capital Management first reported a position in WGS in Q1 2026 and has held it in 3 quarters since. 218 funds tracked by Wall St. Rank hold WGS as of Q3 2026.

  • Vanguard Capital Management held 948,762 shares of GeneDx Holdings worth $68.6M as of Q3 2026.
  • Vanguard Capital Management bought 69,759 GeneDx Holdings shares in Q3 2026, an estimated $5.41M.
  • GeneDx Holdings made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1735 holding.
  • Vanguard Capital Management first reported a position in GeneDx Holdings in Q1 2026 and has held it in 3 quarters since.
  • 218 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.